News room
Technophage is looking for a Quality Control Manager to join the team
Technophage is currently looking for a Quality Control Manager to join our Quality and Production team. Technophage requires academic degree...
Technophage announces dosing of first patient in Phase 2b Clinical Trial for TP-102 in Diabetic Foot Ulcers
Technophage, a biopharmaceutical company specializing in the development and production of biologics, particularly bacteriophage-based products, has...
TechnoPhage starts Phase 2b study of TP-102 bacteriophage treatment for diabetic foot infections
TechnoPhage, a clinical-stage biopharmaceutical company specializing in the development of phage treatments targeting specific pathogenic bacteria,...
Technophage was recognized with ‘PME líder 2023’ distinction by IAPMEI
We are thrilled to announce that Technophage has been recognized by IAPMEI, I.P. - Agência para a Competitividade e Inovação (Agency for...
Technophage honored with a Healthcare & Pharmaceutical Award
For eight years in a row, the Healthcare & Pharmaceutical Awards have recognized the pioneers transforming our healthcare field. We are thrilled...